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Abstract
Background: To evaluate the association between mood and anxiety disorders and thyroid
autoimmunity in a community sample. Methods: A community based sample of 222 subjects was
examined. Psychiatric diagnoses were formulated using the International Composite Diagnostic
Interview Simplified (CIDIS), according to DSM-IV criteria. All subjects underwent a complete
thyroid evaluation including physical examination, thyroid echography and measure of serum free
T4 (FT4), free T3 (FT3), thyroid-stimulating hormone (TSH) and anti-thyroid peroxidase
autoantibodies (anti-TPO).
Results: 16.6% of the overall sample had an anti-TPO value above the normal cut-off. Subjects with
at least one diagnosis of anxiety disorders (OR = 4.2, C.L. 95% 1.9–38.8) or mood disorders (OR
= 2.9, Cl 95% 1.4–6.6, P < 0.011) were positive for serum anti-TPO more frequently than subjects
without mood or anxiety disorders. A statistically significant association with anti-TPO+ was found
in Anxiety Disorder Not Otherwise Specified (OR = 4.0, CL 95% 1.1–15.5), in Major Depressive
Episode (OR = 2.7, CL 95% 1.1–6.7) and Depressive Disorder Not Otherwise Specified (OR = 4.4,
S CL 95% 1–19.3).
Conclusions:  The study seems to suggest that individuals in the community with thyroid
autoimmunity may be at high risk for mood and anxiety disorders. The psychiatric disorders and
the autoimmune reaction seem to be rooted in a same (and not easy correctable) aberrancy in the
immuno-endocrine system. Should our results be confirmed, the findings may be of great interest
for future preventive and case finding projects.
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Background
Autoimmune thyroid disease may be linked to depression
[1] and anxiety [2]. Autoimmune disease and depression
are not uncommon: the prevalence of autoimmune thy-
roid disease in the community ranged from 4 to 25% [3]
and lifetime prevalence of Major Depressive Disorder
ranged from 6 to 17% [4]. Thus the association may have
a great relevance in terms of public health and prevention.
The purpose of this investigation was to evaluate the rela-
tionship between mood and anxiety disorders and thyroid
autoimmunity in a community survey. This research was
carried out on the data base of two epidemiological stud-
ies aimed at defining the prevalence of psychiatric [5] and
thyroid diseases [6] in Sardinia. On planning these sur-
veys, researchers agreed to evaluate a representative sub-
sample of a defined geographical area common to both
endocrinological and psychiatric epidemiological surveys.
This paper present the results of the cross psychiatric and
endocrinological evaluation from the common areas of
the two surveys.
Methods
The sample was extracted by randomization (1/10) subse-
quent to stratification according to age and sex, from the
records of 2 Sardinian villages. Probands were interviewed
face to face in their homes by specifically trained physi-
cians. Two standardized forms were used to acquire infor-
mation concerning: demographic data, state of health and
use of social and health services. Psychiatric diagnosis was
made using the Italian Simplified version of the Compos-
ite International Diagnostic Interview (CIDIS) [7]. The
computer elaboration of data obtained enabled preva-
lence of psychiatric disorders according to DSM-IV [8]
diagnostic criteria to be calculated.
Anti-thyroid peroxidase autoantibodies (anti-TPO), con-
sidered as the most sensitive and specific marker of thy-
roid autoimmunity [9] was determined by RIA (Sorin
Biomedica Diagnostics, Saluggia, Italy) with a cut-off
value of 20 IU/ml.
All subjects underwent a complete thyroid evaluation
including physical examination, thyroid echography and
measure of serum free T4 (FT4), free T3 (FT3), thyroid-
stimulating hormone (TSH) and anti-thyroid peroxidase
autoantibodies (anti-TPO). FT4 and FT3 were measured
by means of a chromatographic method based on separa-
tion of free T4 on Lisophase columns (Technogenetics,
Milan, Italy; normal values: FT4 6.6–16 pg/ml; FT3 2.8–
5.6 pg/ml). TSH was measured by a chemiluminescent
method (Ortho-Clinical Diagnostics Amersham, U.K.)
with normal values ranging from 0.3–3.0 µU/ml. Thyroid
echography was performed using a "real time" echograph
(ALOKA Mod SSD 500 with a small parts 7.5).
The association of anti- TPO+ with the main diagnoses
deriving from CIDIS interview was calculated using Odds
Ratio. Statistical significance was calculated using the X2
test in 2 × 2 tables. Odds Ratio confidence intervals were
calculated through application of the method of Miet-
tinen [10].
Multivariate Logistic Regression was performed in order
to evaluate the possible influences of gender and age on
the association between anti-TPO+ and mood or anxiety
disorders. The analysis was carried out considering mood
(or anxiety) disorders as dependent variable, and anti-
TPO+ (presence vs absence), gender (female vs male) and
age (≤ 44 vs > 44) and their second order interactions as
independent variables, by means of backward stepwise
procedure; interactions lacking evidence of association (p
> 0.20) were eliminated from the models.
Results
From a total of 261 subjects identified (age >18 years),
222 (85.1%), 127 females (57.2%), and 95 males
(42.7%); over 44 years 127 (57.2%), 79 females (62.2%,)
48 males (37.7%), agreed to take part in the study whilst
20 (8,7%) refused to participate and 19 (7.3%) could not
be traced. The final sample did not differ respect to the
population of origin with reference to the variables
applied in stratification.
The lifetime prevalence of anxiety disorders in the sample
was: Generalized Anxiety Disorder (GAD) 11.3%, Panic
Disorder (PD) 2.7%, Anxiety Disorder Not Otherwise
Specified (ADNOS) 5.4%, Social Phobia (SP) 5.4%;
18.5% had been diagnosed with at least one of these anx-
iety disorders. With regard to mood disorders, Major
Depressive Episode (MDE) was present in 14.4%, Dys-
thymic Disorder (DD) in 2.7%, Depressive Disorder Not
Otherwise Specified (DDNOS) in 4.0%; 18.9% had at
least one of the above mentioned depressive disorders.
1.1% of the overall sample was affected by hypothy-
roidism, 16.6% had an anti-TPO value above the normal
cut-off (anti-TPO+).
Table 1 shows the association between anti-TPO+ and
lifetime psychiatric diagnosis. Subjects with at least one
lifetime diagnosis of anxiety disorders or one lifetime
diagnosis of mood disorders presented anti-TPO+ more
frequently than subjects without mood or anxiety disor-
ders. An association with anti-TPO+ was found in
ADNOS, in MDE and DDNOS. The attributable risk for
ADNOS was 0.54, 0.37 for MDE and 0.34 for DDNOS,
other conditions as PD and DD presented very high attrib-
utable risk.BMC Psychiatry 2004, 4:25 http://www.biomedcentral.com/1471-244X/4/25
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The Multivariate Logistic Regression showed that gender
and age do not interact with anti-TPO either in mood
(interaction anti-TPO-gender p = 0.97, OR 1.03, CI 95%,
0.19–5.48; interaction anti-TPO-age p = 0.62, OR = 1.52,
CI 95%, 0.30–7.77), or in anxiety disorders (interaction
anti-TPO-gender p = 0.93, OR = 0.93, CI 95%, 0.18–4.80;
interaction anti-TPO-age p = 0.67, OR = 0.70, CI 95%,
0.14–3.64). Interactions were therefore eliminated from
the models.
The final Logistic Regression models clearly indicated that
gender and age do not influence the risk of one mood or
anxiety diagnosis either as independent variables or as
confounders (Table 2, Table 3 and Table 4).
Discussion
The present study indicates an association between the
presence of a lifetime diagnosis of mood or anxiety disor-
der and anti-TPO+ in a general population sample which
had not been selected from medical or psychiatric health
facilities. This association is independent by gender and
age. Regarding specific diagnosis, MDE, DDNOS and
ADNOS were associated with anti-TPO+.
This finding is consistent with several previous clinical
studies providing evidence for a significant association of
mood disorders or post-partum depression and symp-
tomless autoimmune thyroiditis with or without sub-clin-
ical hypothyroidism [11]. Association between
hypothyroidism and mood disorders is however contro-
versial as other authors maintain that bipolar disorders
rather than unipolar depression are characterized by an
increased risk for the presence of anti-thyroid antibodies
[11]. However, a study performed by Fountoulakis and
collaborators [1] recently found a link between autoim-
mune thyroid disease and Unipolar Depression. In this
study, compared to control patients all depressive sub-
types had significantly higher thyroid binding inhibitory
immunoglobulins, and atypical patients had significantly
higher thyroid microsomal antibodies. Thyroid function
markers Free Triiodothyronine (FT3), Free Thyroxine
(FT4), and Thyroid Stimulating Hormone (TSH) were
normal in all subjects suggesting that Unipolar Depres-
sion might be characterized by a "low-thyroid function
syndrome".
A sub-clinical dysfunction of axis Thyrotropin Releasing
Hormone (TRH) – Thyroid Stimulating Hormone (TSH)
with consequent alteration of circadian rhythms of TSH
has been hypothesized in some depressive disorders.
Indeed, this hypothesis may explain why some forms of
mood disorders were associated with anti-TPO+ or thy-
roid autoimmunity without hypothyroidism, as defined
by routine blood tests. A slight reduction in thyroid hor-
mone secretion such as that found in sub-clinical
hypothyroidism may affect cognition and mood [12]. At
variance with other tissues which mainly rely on peripher-
ally generated Triiodothyronine, the brain utilizes prefer-
entially circulating thyroxine directly secreted by the
thyroid gland and may become hypothyroid before other
organs [13].
Moreover, a study carried out in a large community sam-
ple found no association between thyroid dysfunction,
including hypothyroidism defined by thyroid blood test,
and the presence of depression or anxiety symptoms [14].
This survey is rather limited due to the fact that the pres-
ence of depression or anxiety symptoms was defined
using a self-rating scale, whilst in the present study depres-
sion and anxiety disorders were diagnosed by means of a
structured psychiatric interview according to an interna-
tional classifications. However, the link between thyroid
autoimmunity and depression may involve other mecha-
nisms related to the autoimmune pathogenesis of thyroid
Table 1: Association between positivity anti-TPO (anti-TPO+), mood and anxiety diagnosis.
Diagnosis Prev.nce N (%) Anti-TPO+ N (%) OR IC 95% χ2P A t t . a b l e  R i s k
One Anxiety Diagnosis 
GAD+PD+SP+ADNOS
41 (18.5) 15 (36.6) 4.2 1.9/38.8 12.6 0.001 0.54
One Mood Diagnosis 
MDE+DD+DDNOS
42 (18.9) 13 (30.9) 2.9 1.4/6.6 6.4 0.011 0.37
GAD 25 (11.3) 8 (32) 2.7 0.97/7.5 3.6 0.058 0.35
PD 6 (2.7) 3 (50) 5.4 0.7/37.3 2.8 0.096 0.68
SP 12 (5.4) 4 (40) 3.6 0.7/7.6 2.5 0.111 0.52
ADNOS 12 (5.4) 5 (41.7) 4.0 1.1/15.5 3.9 0.045 0.55
MDE 32 (14.4) 10 (31.2) 2.7 1.1/6.7 4.6 0.033 0.34
DD 6 (2.7) 2 (50) 5.2 0.3/16.8 1.3 0.250 0.67
DDNOS 9 (4.0) 4 (44.4) 4.4 1/19.3 3.8 0.049 0.60
GAD: Generalized Anxiety Disorder; PD: Panic Disorder; SP: Social Phobia; ADNOS: Anxiety Disorder Not Otherwise Specified; MDE: Major 
Depressive Episode; DD: Dysthymic Disorder; DDNOS: Depressive Disorder Not Otherwise Specified.BMC Psychiatry 2004, 4:25 http://www.biomedcentral.com/1471-244X/4/25
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disease rather than hypothyroidism. Since several neu-
roendocrine secretory systems are involved in the control
of immune reaction, a common neuroendocrine dysregu-
lation involving cytokines might concur towards the
pathogenesis of both affective disorders and autoimmune
disease. Recent evidence suggests that thyroid autoimmu-
nity may be affected by the Hypothalamic-Pituitary-Adre-
nal axis (HPA) through the balance of proinflammatory
and antiinflammatory cytokines [15]. In line with this
view, the increased frequency of post-partum depression,
associated to the fact that pregnancy would seem to be a
"protected" period, could explain at least in part the con-
sequences on thyroid autoimmunity elicited by HPA-
related modifications to the immunitary axis. Indeed,
similar phenomena are observed in rheumatoid arthritis
and multiple sclerosis [16,17].
With regard to the public heath aspects of this research,
should these findings be confirmed, they would consti-
tute a most important public health issue, due to the high
attributable risk found. The attributable risk is a useful
measure to document the burden of risk to a community.
Attributable risk depends both on the magnitude of rela-
tive risk and on the prevalence of the risk factor in the
population [4]. The high attributable risk of autoimmune
thyroid for Major Depressive Disorder and anxiety and
depressive sub-threshold syndromes may have
implication for the development of preventive interven-
tions. Particularly, further longitudinal studies will be
required to confirm whether anxiety and depressive
disorders are a consequence and not a cause of thyroid
autoimmunity.
Limitations
The potential of the study is reduced by the small sample
size, particularly regard to psychiatric diagnoses less fre-
quently observed in the general population, such as Panic
Disorder; the extension of the findings is therefore rather
limited.
Table 2: Frequency of anti-TPO+ in to the sample according sex and age and one mood diagnosis (OMD) and one anxiety diagnosis 
(OAD) diagnosis for multivariate logistic regression.
Age Sex N anti-TPO+ (%) OMD (%) OMD (%) #anti-TPO+ OAD (%) OAD (%) #anti-TPO+
<45 Female 79 17 (21.5) 17 (21.5) 6 (35.2) 13 (16.4) 6 (35.2)
<45 Male 48 8 (16.6) 7 (14.5) 2 (24) 7 (14.5) 3 (37.5)
>44 Female 48 7 (14.5) 10 (20.8) 3 (42.8) 14 (29.1) 4 (57.1)
>44 Male 47 5 (10.6) 8 (17.2) 2 (40) 7 (15.1) 2 (40)
#TPO+ in the sub-group is the total
Table 3: Multivariate logistic regression: effect of anti-TPO+ on risk of one mood diagnosis considering gender (female vs male) and age 
(≤ 44 vs > 44) effects.
pO R C I  9 5 %
anti-TPO+ vs anti-TPO- 0.01 2.89 1.31–6.38
Gender (F vs M) 0.37 1.38 0.68–2.82
Age (≤ 44 vs > 44) 0.71 1.14 0.57–2.30
Table 4: Multivariate Logistic Regression: effect of anti-TPO+ on risk of one anxiety diagnosis considering gender (Female vs Male) and 
age (≤ 44 vs > 44) effects.
p OR CI 95%
anti-TPO+ vs anti-TPO- 0.001 4.50 2.02 – 10.04
Gender (F vs M) 0.23 1.58 0.75 – 3.31
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Conclusions
This study indicates an association between the presence
of a lifetime diagnosis of mood or anxiety disorder and
anti-TPO+. The psychiatric disorders and the autoim-
mune reaction seem to be rooted in a same (and not easy
correctable) aberrancy in the immuno-endocrine system.
If the findings are confirmed, they may prove to be of
interest for future projects of case finding: a systematic
screening for mood disorders in anti-TPO+ subjects and a
systematic evaluation for thyroid diseases and thyroid
autoimmunity in subjects with mood disorders may be
advisable.
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